In conclusion, our in vitro and in vivo data indicate that the novel Reln‐del mice, using CRISPR/Cas9, which partially mimicked schizophrenia‐like behavior, provide a novel platform for elucidation of the pathogenesis underlying schizophrenia and the development of reelin‐based therapies. This evidence concerns the gene RELN and schizophrenia.